文献速递新生儿儿童神经与发育行为

低温治疗缺氧缺血性脑病新生儿中低剂量氢化可的松与安慰剂的随机对照研究

A Randomized Controlled Study of Low-Dose Hydrocortisone Versus Placebo in Dopamine-Treated Hypotensive Neonates Undergoing Hypothermia Treatment for Hypoxic-Ischemic Encephalopathy.
PubMed 文献 · J Pediatr · 2019-05-30

OBJECTIVE: To investigate whether hydrocortisone supplementation increases blood pressure and decreases inotrope requirements compared with placebo in cooled, asphyxiated neonates with volume-resistant hypotension.…

要点

  • 低温治疗的窒息新生儿容量抵抗性低血压,加用氢化可的松可更快达标血压。
  • 氢化可的松组2小时内MAP升高≥5 mmHg的比例为94%,安慰剂组为58%。
  • 两组短期临床结局相似,但氢化可的松减少心血管支持时间和肌力药物用量。

核心结论

  • 在低温治疗的窒息新生儿容量抵抗性低血压中,氢化可的松能有效升高血压并减少肌力药物需求。

研究设计与样本

  • 患儿在低温治疗期间随机接受氢化可的松0.5 mg/kg/6小时或安慰剂,均加用标准多巴胺治疗。

主要发现

  • 符合方案分析中,回归模型预测氢化可的松使MAP升高4 mmHg的效应相当于多巴胺15 μg/kg/min。
  • 两组短期临床结局相似。

关键数值与推荐

  • 容量抵抗性低血压定义为平均动脉压(MAP)低于胎龄周数。
  • 氢化可的松剂量为0.5 mg/kg/6小时,在低温治疗期间加用标准多巴胺治疗。
  • 主要达标指标为随机化后2小时内MAP至少升高5 mmHg。

临床怎么用

  • 对低温治疗的窒息新生儿出现容量抵抗性低血压时,可考虑加用低剂量氢化可的松以提升血压并减少肌力药物用量。
  • 使用氢化可的松前可关注血清皮质醇水平,低皮质醇提示肾上腺功能不适当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether hydrocortisone supplementation increases blood pressure and decreases inotrope requirements compared with placebo in cooled, asphyxiated neonates with volume-resistant hypotension. STUDY DESIGN: A double-blind, randomized, placebo-controlled clinical trial was conducted in a Level III neonatal intensive care unit in 2016-2017. Thirty-five asphyxiated neonates with volume-resistant hypotension (defined as a mean arterial pressure [MAP] < gestational age in weeks) were randomly assigned to receive 0.5 mg/kg/6 hours of hydrocortisone or placebo in addition to standard dopamine treatment during hypothermia. RESULTS: More patients reached the target of at least 5-mm Hg increment of MAP in 2 hours after randomization in the hydrocortisone group, compared with the placebo group (94% vs 58%, P = .02, intention-to-treat analysis). The duration of cardiovascular support (P = .001) as well as cumulative (P < .001) and peak inotrope dosage (P < .001) were lower in the hydrocortisone group. In a per-protocol analysis, regression modeling predicted that a 4-mm Hg increase in MAP in response to hydrocortisone treatment was comparable with the effect of 15 μg/kg/min of dopamine in this patient population. Serum cortisol concentrations were low before randomization in both the hydrocortisone and placebo groups (median 3.5 and 3.3 μg/dL, P = .87; respectively), suggesting inappropriate adrenal function. Short-term clinical outcomes were similar in the 2 groups. CONCLUSIONS: Hydrocortisone administration was effective in raising the blood pressure and decreasing inotrope requirement in asphyxiated neonates with volume-resistant hypotension during hypothermia treatment. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02700828.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Kovacs K, Szakmar E, Meder U, et al. A Randomized Controlled Study of Low-Dose Hydrocortisone Versus Placebo in Dopamine-Treated Hypotensive Neonates Undergoing Hypothermia Treatment for Hypoxic-Ischemic Encephalopathy. J Pediatr. 2019. PMID: 31155392. doi:10.1016/j.jpeds.2019.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。